Clinical Trial: A Study to Assess the Effect of Subcutaneous Injection Site on the Pharmacokinetics of Pegozafermin in Healthy Participants

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07835243) titled 'A Study to Assess the Effect of Subcutaneous Injection Site on the Pharmacokinetics of Pegozafermin in Healthy Participants' on Sept. 17.

Brief Summary: The purpose of this study is to evaluate the pharmacokinetics (PK) of a single subcutaneous (SC) dose of pegozafermin administered in the abdomen, thigh, or upper arm in healthy participants.

Study Start Date: Oct. 07

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: Pegozafermin

Pergozafermin will be administered as specified in the protocol.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hoffmann-La Roche

Disclaimer: Curated by HT Syndication...